Medical Marijuana, Inc. Subsidiary HempMeds® Brasil To Hold Its Second Doctor Symposium on Medical Cannabis in Sao Paulo, Brazil

Amyotrophic Lateral Sclerosis (ALS) and Psoriasis Patients Receive Brazilian Government Permission to Be Treated with Medical Marijuana, Inc. Subsidiary, HempMeds® Brasil, Flagship Product RSHO™

Brazilian Doctors Have Been Prescribing RSHO™ to Treat Patients Suffering From Effects of ALS and Psoriasis SAN DIEGO, July 19, 2017 — Medical Marijuana, Inc. (MJNA) is the first publicly traded cannabis company in the United States. Its subsidiary HempMeds®...